Copyright
©The Author(s) 2020.
World J Clin Cases. Jan 6, 2021; 9(1): 24-35
Published online Jan 6, 2021. doi: 10.12998/wjcc.v9.i1.24
Published online Jan 6, 2021. doi: 10.12998/wjcc.v9.i1.24
Variable | No. of patients (%) | HR | 95%CI | P value |
Sex | 0.488 | |||
Female | 28 (10.8) | Reference | ||
Male | 231 (89.2) | 1.199 | 0.717-2.006 | 0.488 |
Age, yr | 0.776 | |||
≤ 60 | 88 (34.0) | Reference | ||
61-70 | 112 (43.2) | 0.942 | 0.671-1.322 | 0.728 |
≥ 71 | 59 (22.8) | 1.082 | 0.729-1.606 | 0.695 |
Marital status | 0.152 | |||
Married | 187 (72.2) | Reference | ||
Single | 57 (22.0) | 1.400 | 0.996-1.968 | 0.053 |
Unknown | 15 (5.8) | 1.151 | 0.584-2.266 | 0.685 |
Insurance | 0.005 | |||
Insured | 217 (83.8) | Reference | ||
Uninsured | 4 (1.5) | 5.272 | 1.904-14.599 | 0.001 |
Unknown | 38 (14.7) | 0.918 | 0.608-1.358 | 0.683 |
Race | 0.087 | |||
Hispanic (all races) | 19 (7.3) | Reference | ||
Non-Hispanic American Indian/Alaska Native | 2 (0.8) | 0.358 | 0.046-2.762 | 0.324 |
Non-Hispanic Asian or Pacific Islander | 5 (1.9) | 1.229 | 0.395-3.818 | 0.722 |
Non-Hispanic Black | 10 (3.9) | 2.293 | 0.987-5.326 | 0.054 |
Non-Hispanic White | 223 (86.1) | 0.962 | 0.534-1.734 | 0.898 |
Grade | 0.136 | |||
I + II | 12 (4.6) | Reference | ||
III + IV | 214 (82.6) | 0.978 | 0.499-1.918 | 0.949 |
Unknown | 33 (12.7) | 0.595 | 0.267-1.326 | 0.204 |
TNM stage | 0.000 | |||
I | 34 (13.1) | Reference | ||
II | 59 (22.8) | 1.919 | 1.031-3.573 | 0.040 |
III | 130 (50.2) | 2.931 | 1.662-5.168 | 0.000 |
IV | 36 (13.9) | 4.936 | 2.610-9.334 | 0.000 |
T stage | 0.048 | |||
T1 | 51 (19.7) | Reference | ||
T2 | 30 (11.6) | 1.757 | 0.992-3.112 | 0.053 |
T3 | 164 (63.3) | 1.705 | 1.120-2.596 | 0.013 |
T4 | 14 (5.4) | 2.334 | 1.121-4.861 | 0.024 |
N stage | 0.000 | |||
N0 | 86 (33.2) | Reference | ||
N1 | 100 (38.6) | 1.841 | 1.263-2.682 | 0.001 |
N2 | 47 (18.1) | 2.666 | 1.697-4.189 | 0.000 |
N3 | 26 (10) | 3.836 | 2.316-6.353 | 0.000 |
M stage | 0.058 | |||
M0 | 246 (95) | Reference | ||
M1 | 13 (5.0) | 1.809 | 0.981-3.337 | 0.058 |
LODDS | 0.000 | |||
LODDS1 (4.55 ≤ LODDS ≤ 1.90) | 134 (51.7) | Reference | ||
LODDS2 (1.89 ≤ LODDS ≤ 0.15) | 99 (38.2) | 1.864 | 1.353-2.569 | 0.000 |
LODDS3 (0.16 ≤ LODDS ≤ 4.27) | 26 (10) | 4.204 | 2.656-6.655 | 0.000 |
Radiation therapy | 0.085 | |||
No radiation and/or cancer-directed surgery | 67 (25.9) | Reference | ||
Radiation prior to surgery | 162 (62.5) | 1.010 | 0.710-1.435 | 0.958 |
Radiation after surgery | 25 (9.7) | 1.779 | 1.061-2.983 | 0.029 |
Radiation before and after surgery | 5 (1.9) | 1.672 | 0.516-5.421 | 0.392 |
Chemotherapy | 0.719 | |||
No or unknown | 49 (18.9) | Reference | ||
Yes | 210 (81.1) | 1.073 | 0.730-1.578 | 0.719 |
- Citation: Wang F, Gao SG, Xue Q, Tan FW, Gao YS, Mao YS, Wang DL, Zhao J, Li Y, Yu XY, Cheng H, Zhao CG, Mu JW. Log odds of positive lymph nodes is a better prognostic factor for oesophageal signet ring cell carcinoma than N stage. World J Clin Cases 2021; 9(1): 24-35
- URL: https://www.wjgnet.com/2307-8960/full/v9/i1/24.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v9.i1.24